These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7688338)

  • 1. Insulin-like growth factor binding protein-1 levels in diabetic proliferative retinopathy.
    Hopkins KD; Brart DO; Russell-Jones DL; Chignell AH; Sönksen PH
    Horm Metab Res; 1993 Jun; 25(6):331-2. PubMed ID: 7688338
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics.
    Waldbillig RJ; Jones BE; Schoen TJ; Moshayedi P; Heidersbach S; Bitar MS; van Kuijk FJ; de Juan E; Kador P; Chader GJ
    Curr Eye Res; 1994 Jul; 13(7):539-46. PubMed ID: 7523030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance and detection of insulin-like growth factor I in vitreous with proliferative retinal diseases by radioimmunoassay].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):122-5. PubMed ID: 7656720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
    Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
    Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
    Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
    Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The content of the PAMG-1 protein that binds insulin-like growth factor I (somatomedin C) in the blood serum of diabetic patients].
    Nazimova SV; Obernikhin SS; Boltovskaia MN; Starosvetskaia NA; Zaraĭskiĭ EI; Fuks BB
    Biull Eksp Biol Med; 1993 Sep; 116(9):302-4. PubMed ID: 7509650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
    Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
    Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Goto H; Iwasaki T
    Retina; 2010 Feb; 30(2):339-44. PubMed ID: 20142713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
    Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
    Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of growth hormone in proliferative diabetic retinopathy. Clinical and immunohistochemical aspects].
    Negre F; Fredj-Reygrobellet D; Harroche S; Taieb JC
    Ophtalmologie; 1990; 4(1):56-9. PubMed ID: 2250943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Placental protein 12 (PP 12)/insulin-like growth factor binding protein (IGF-bp) in pregnancy in metabolically healthy patients and diabetic patients with retinopathy].
    Briese V; Than GN; Szabo DG; Strache RR; Glöckner E; Szilagyi A; Hopp H
    Zentralbl Gynakol; 1989; 111(18):1215-9. PubMed ID: 2480035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients.
    Lønning PE; Hall K; Aakvaag A; Lien EA
    Cancer Res; 1992 Sep; 52(17):4719-23. PubMed ID: 1380889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.